English
Quavonlimab, CAS 2254059-25-9
Quavonlimab, CAS 2254059-25-9
Artikelnummer
MEXHY-P99809-1
Verpackungseinheit
1 mg
Hersteller
MedChemExpress
Verfügbarkeit:
wird geladen...
Preis wird geladen...
Product Description: Quavonlimab (MK-1308) is a novel anti-CTLA-4 antibody[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Perets R, et al. Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer. Ann Oncol. 2021;32(3):395-403.
CAS Number: 2254059-25-9
Molecular Weight: N/A
Compound Purity: 99.0
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: CTLA-4
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Perets R, et al. Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer. Ann Oncol. 2021;32(3):395-403.
CAS Number: 2254059-25-9
Molecular Weight: N/A
Compound Purity: 99.0
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: CTLA-4
| Artikelnummer | MEXHY-P99809-1 |
|---|---|
| Hersteller | MedChemExpress |
| Hersteller Artikelnummer | HY-P99809-1 |
| Verpackungseinheit | 1 mg |
| Mengeneinheit | STK |
| Konjugat | Unconjugated |
| Produktinformation (PDF) | Download |
| MSDS (PDF) |
|
Verwandte Artikel
Markieren Sie die Artikel, um Sie dem Warenkorb hinzuzufügen oder
Immer für Sie da
Dr. Andreas Bergmann
